Accession Number: | 0001562180-21-005174 |
Date: | 2021-08-02 |
Issuer: | BLUEBIRD BIO, INC. (BLUE) |
Original Submission Date: |
BAIRD WILLIAM D III
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-08-02 | A | 33,585 | a | $0.00 | 69,114 | direct | ||
COMMON STOCK | 2021-08-02 | A | 33,584 | a | $0.00 | 102,698 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | restricted stock unit awards vest over a two-year period at the rate of 40% on august 2, 2022 and 60% on august 2, 2023. |
f2 | restricted stock unit awards shall vest upon the satisfaction of certain performance criteria. |